Director, BRAF Pan-Tumor Marketing (Secondment - 8 Months)

Pfizer • New York City, NY

15d • Hybrid

About The Position

BRAFTOVI (encorafenib) & MEKTOVI (binimetinib) are key therapies within the Pfizer Oncology Precision Medicine franchise, with a strong future of growth through the end of the decade. The portfolio covers three indications: Metastatic Melanoma: BRAFTOVI + MEKTOVI received approval (COLUMBUS) in BRAF mutant metastatic melanoma in 2018. Colon Cancer: BRAFTOVI + cetuximab received approval as the first and only targeted therapy BRAF mutant metastatic colorectal cancer in April 2020 (BEACON); 1L indication approval in Dec 2024 (BREAKWATER). Lung Cancer: BRAFTOVI + MEKTOVI received approval (PHAROS) for BRAF mutant metastatic lung cancer in 2023. There is significant growth expected from this portfolio over the next 3-4 years and will be an important priority brand within Pfizer Oncology. The Director, Pan-Tumor & Melanoma Marketing will report to the US Mel/CRC Marketing Team Lead. This position requires strong strategic, analytical and execution skills, interpersonal and communication skills, and agility to learn and work across multiple stakeholders. The Director, BRAF Pan-Tumor & Melanoma Marketing will partner with the Melanoma Indication Lead and Mel/CRC Marketing TL to deliver on key BRAFTOVI & MEKTOVI Melanoma strategies, as well as drive multiple pan-tumor marketing efforts across the three indications of BRAFTOVI & MEKTOVI.

Requirements

• BA/BS with 8+ years of experience.
• Has demonstrated experience that focus on the customer and leverages innovative ways of reaching those customers.
• Strong project management skills, including ability to lead multiple projects simultaneously.
• Ability to translate strategy and analysis to a tactical, executable level to drive brand success.
• Strong team player with demonstrated ability to collaborate with experts from cross-functional areas.
• Strong business acumen with excellent verbal and written communication skills for a wide variety of audiences, including senior management.
• High-energy, proactive self-starter who has the initiative to function autonomously and the confidence and ingenuity to initiate, create, and innovate.
• Demonstrated ability to manage advertising and other agencies to produce resources that impact business performance.

Nice To Haves

• MBA/MS with 7+ years of experience; OR PhD or JD with 5+ years of experience.
• Pharmaceutical marketing preferred.
• Previous in-line US/global Marketing experience and/or understanding of advanced Melanoma landscape preferred.

Responsibilities

• Lead development of Media Strategy (HCP and Consumer) in collaboration with indication leads and lead execution of media tactics with agency(s).
• Manage execution of Pan-Tumor marketing campaign and cross-tumor marketing execution.
• Lead peer-to-peer strategy and third party programs, including management of speaker program content and speaker bureau.
• Lead Congress Strategy and act as escalation point for congress execution with cross-functional partners and team.
• Liaise with Account Marketing Lead and Payer Marketing teams to ensure that brand strategies are executed by those marketing teams.
• Lead development and execution of Melanoma promotional efforts across all key stakeholders (i.e. HCPs, patients, health systems).
• Collaborate with Melanoma Strategy Lead in development of Melanoma Strategy for BRAFTOVI & MEKTOVI.
• Engage with field team members and KOLs as appropriate to stay up-to-date on Melanoma competitive landscape and key business drivers.
• Collaborate with ISE (Insights Strategy & Execution) Team to derive insights from market research and performance and analytics reports across the Melanoma business.

What This Job Offers

• Job Type: Full-time
• Career Level: Director
• Number of Employees: 5,001-10,000 employees